AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia
Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype.
As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency.
Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available.
“People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, including organ failure due to iron overload,” said Dr. Michele Lipucci di Paola, of AVLT, patient representative at EMA.
Dr. Chris Sotirelis, an expert patient at EMA said: “The approval of Zynteglo™ is a breakthrough that offers a unique treatment choice to patients, as the first one-time gene therapy that addresses the underlying genetic cause of transfusion-dependent β-thalassaemia.
The opinion adopted by the CHMP at its March 2019 meeting is an intermediary step for Zynteglo™ to path to reach patients. The CHMP opinion, once confirmed by the European Commission, will result in an EU-wide marketing authorisation. After that decisions about price and reimbursement will take place at the level of each Member State, taking into account the potential role/use of this medicine in the context of the national health system of that country.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190325005774/en/
Contact information
AVLT
Dr. Michele Lipucci di Paola
+39 3382104475
mlipucci@yahoo.com
UKTS
Dr.
Chris Sotirelis
+44 7979594067
chris.sotirelis@gmail.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System24.4.2024 19:00:00 EEST | Press release
From April 16th to 17th, the BloombergNEF (BNEF) Summit was held in New York, USA. The BNEF Summit brings together energy, finance, and technology professionals to facilitate the exchange of ideas, insights, and connections. This was Hithium's first time attending after its global launch in 2023. Hithium was also invited to host a roundtable discussion on the topic of "Next Generation Battery Energy Storage System: Latest Technology Trends and Impact on Project Economics," led by Hithium Director of Global Applications Engineering, Neil Bradshaw. The discussion focused on the future development trends of energy storage and included insights on Hithium's technology innovations, global application practices, and international development for global energy green transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423336349/en/ BNEF summit roundtable hosted by HiTHIUM (Photo: Business Wire) Hithium’s advantages on
LTIMindtree Closes FY24 with a Strong Order Inflow of $5.6 Bn; up 15.7% YoY24.4.2024 18:01:00 EEST | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended March 31, 2024, as approved by its Board of Directors. “We closed FY24 amidst a tough macro environment and delivered a resilient performance with full-year revenue growth of 4.4% in USD terms and an EBIT margin of 15.7%. Our order inflow for the full year at USD 5.6 billion registered a 15.7% growth over FY23. This growth reflects the positive outcomes of our positioning as an organization with scale, expanded capabilities, and larger partnerships. As the market dynamics evolve, we are excited to be part of innovations, partnerships, and initiatives that our clients will embark on in FY 25.” -Debashis Chatterjee, Chief Executive Officer and Managing Director Key financial highlights: Quarter ended March 31, 2024 In USD: - Revenue at $1,069.4 million (-1.3% Q-o-Q / +1.1% Y-o-Y) - Net profit at $132.4 mill
LYCRA® Brand Launches New Customizable Fit Solution at Kingpins Amsterdam24.4.2024 18:00:00 EEST | Press release
The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel industry, announced the launch of a revolutionary new targeted shaping innovation for stretch denim at a press conference at Kingpins Amsterdam today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424493653/en/ The LYCRA Company launches a revolutionary new targeted shaping innovation for stretch denim at Kingpins Amsterdam Spring 2024: LYCRA FitSense® denim technology. (Photo: Business Wire) LYCRA FitSense® denim technology is a shaping technology engineered to provide a unique fit solution to consumers of all body types and shapes. Its advanced shaping effect delivers targeted support to common trouble spots that can impact garment fit, such as the tummy and waist, thighs and rear, offering a customizable fit solution that is a breakthrough for the denim industry. “Targeted support is engineered in
Strike Launches Bitcoin App in Europe24.4.2024 17:00:00 EEST | Press release
Strike, the global bitcoin app, today announced the launch of its platform to eligible customers in Europe. Strike Europe introduces a comprehensive suite of features designed to empower millions of people with access to Bitcoin. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424407807/en/ Strike Europe App (Photo: Business Wire) Customers can sign up in a few clicks, seamlessly and securely buy bitcoin with free, instant, and unlimited deposits, and sell, send, and withdraw just as easily. The platform also facilitates global payments and offers advanced Bitcoin and Lightning wallet services. Strike is available for download on iOS and Android app stores. Key features of Strike Europe include: Buy bitcoin directly with free unlimited SEPA Euro deposits from your bank account Sell bitcoin and withdraw the funds directly to your SEPA bank account Withdraw bitcoin to self-custody or send it to any Bitcoin or Lightning walle
Parker Aerospace Joins HyFIVE Consortium to Advance Aviation Liquid Hydrogen Fuel System Development24.4.2024 17:00:00 EEST | Press release
Parker Aerospace, a business segment of Parker Hannifin Corporation, the global leader in motion and control technologies, will participate in the HyFIVE consortium of industry and academic partners developing a world-leading liquid hydrogen fuel system and supply chain supporting zero-emission aviation in the 2030s. In addition to Parker Aerospace, HyFIVE includes fellow industry partners Marshall and GKN Aerospace, as well as academic partners University of Manchester, University of Bath and Cardiff University. The project is supported by the ATI Programme, a partnership between the UK’s Department for Business and Trade, the Aerospace Technology Institute (ATI) and Innovate UK (UKRI). The consortium will receive initial funding of £17 million ($21.5 million) from industry, matched by £20 million ($25 million) from the UK Government. A path to zero emissions flight The objective of the HyFIVE consortium is to develop, test and validate a modular and scalable cryogenic hydrogen fuel s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom